atezolizumab perioperative immunotherapy breast cancer

  • A Critical Review of the IMpassion031 Trial: Evaluating Peri-operative Atezolizumab in Early-Stage Triple-Negative Breast Cancer

    • June 30, 2025
    • Posted by: Editor
    • Categories: DJMI, Vol. 04 No. 06 (2025)
    No Comments
    read more